Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
27 08 2022
Historique:
received: 25 07 2022
revised: 23 08 2022
accepted: 24 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

The results of tuberculosis (TB) screening and reactivation in a cohort of 323 adult patients undergoing haematopoietic stem cell transplantation (HSCT) from 2015 to 2019 at the University Hospital of Tor Vergata, Rome, Italy, were reported. A total of 260 patients, 59 (18.3%) autologous and 264 (81.7%) allogeneic transplants, underwent Interferon Release (IFN)-γ (IGRA) test screening: 228 (87.7%) were negative, 11 (4.2%) indeterminate and 21 (8.1%) positive. Most of the IGRA-positive patients were of Italian origin (95.2%) and significantly older than the IGRA-negative (

Identifiants

pubmed: 36078409
pii: ijerph191710693
doi: 10.3390/ijerph191710693
pmc: PMC9518118
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2017 Feb 16;12(2):e0171358
pubmed: 28208160
J Clin Tuberc Other Mycobact Dis. 2021 Jun 22;24:100253
pubmed: 34278005
Int J Environ Res Public Health. 2019 Dec 24;17(1):
pubmed: 31878124
Epidemiol Prev. 1999 Jan-Mar;23(1):27-36
pubmed: 10356862
Clin Infect Dis. 2019 Aug 16;69(5):869-872
pubmed: 30689792
PLoS One. 2017 Mar 9;12(3):e0173250
pubmed: 28278166
Int J Tuberc Lung Dis. 2021 Dec 1;25(12):964-973
pubmed: 34886925
BMJ Open. 2016 Oct 3;6(10):e012011
pubmed: 27697871
Lancet Infect Dis. 2021 Dec;21(12):1701-1712
pubmed: 34363771
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):573-5
pubmed: 25247435
Bone Marrow Transplant. 2021 Sep;56(9):2241-2247
pubmed: 33966056
Eur Respir J. 2017 Feb 2;49(2):
pubmed: 28153873
Biol Blood Marrow Transplant. 2020 Jul;26(7):1350-1354
pubmed: 32200119
Eur Respir J. 2012 Oct;40(4):990-1013
pubmed: 22496318
Int J Tuberc Lung Dis. 2015 Jan;19(1):58-64
pubmed: 25519791
Int J Infect Dis. 2020 Nov;100:199-206
pubmed: 32920230
BMC Med. 2014 Jul 17;12:120
pubmed: 25034889
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Am J Respir Crit Care Med. 2016 Aug 15;194(4):501-9
pubmed: 26866439
Lancet Infect Dis. 2022 May 27;:
pubmed: 35636446
J Infect. 2019 Nov;79(5):444-453
pubmed: 31473271
Int J Infect Dis. 2022 Mar 5;:
pubmed: 35257904
Eur Respir J. 2015 Oct;46(4):1095-103
pubmed: 26250497

Auteurs

Mirko Compagno (M)

Clinical Infectious Diseases Unit, Tor Vergata Hospital, 00133 Rome, Italy.

Assunta Navarra (A)

Clinical Epidemiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00161 Rome, Italy.

Laura Campogiani (L)

Clinical Infectious Diseases Unit, Tor Vergata Hospital, 00133 Rome, Italy.

Luigi Coppola (L)

Clinical Infectious Diseases Unit, Tor Vergata Hospital, 00133 Rome, Italy.

Benedetta Rossi (B)

Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy.

Marco Iannetta (M)

Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy.

Vincenzo Malagnino (V)

Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy.

Saverio G Parisi (SG)

Department of Molecular Medicine, University of Padova, Via Gabelli, 63, 35100 Padova, Italy.

Benedetta Mariotti (B)

Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
Rome Transplant Network, Tor Vergata University Hospital, 00133 Rome, Italy.

Raffaella Cerretti (R)

Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
Rome Transplant Network, Tor Vergata University Hospital, 00133 Rome, Italy.

William Arcese (W)

Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
Rome Transplant Network, Tor Vergata University Hospital, 00133 Rome, Italy.

Delia Goletti (D)

Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00161 Rome, Italy.

Massimo Andreoni (M)

Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy.

Loredana Sarmati (L)

Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH